Evidence map›Paper›PMID 36894159›Full record

ArticleAmerican journal of perinatology2024

Outcomes among Neonates after a Diagnosis of Persistent or Transient Fetal Growth Restriction Delivered at Term.

Sebastian Z Ramos, Phinnara Has, Alexis C Gimovsky, Valery A Danilack, David A Savitz, Adam K Lewkowitz

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in American journal of perinatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sebastian Z RamosDepartment of Obstetrics and Gynecology, Women & Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.ORCID 0000-0003-1465-5027
Phinnara HasLifespan Biostatistics, Epidemiology, and Research Design (BERD), Rhode Island Hospital, Lifespan Healthcare System, Providence, Rhode Island.
Alexis C GimovskyDepartment of Obstetrics and Gynecology, Women & Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.ORCID 0000-0002-9358-8995
Valery A DanilackCenter for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, Connecticut.ORCID 0000-0001-8165-3457
David A SavitzDepartment of Obstetrics and Gynecology, Women & Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Adam K LewkowitzDepartment of Obstetrics and Gynecology, Women & Infants Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Brown University · USRhode Island Hospital · USYale University · US

Funding

Tufts BIRCWH ProgramK12HD092535 · NICHD · TUFTS UNIVERSITY BOSTON · PI FREUND, KAREN, JAFFE, IRIS Z · 2017 to 2023
$4.3M
Effect Of Iatrogenic Delivery at 34-38 Weeks' Gestation on Pregnancy OutcomeR01HD077592 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI SAVITZ, DAVID A · 2014 to 2017
$1.8M
NICHD NIH HHS K12 HD092535NICHD NIH HHS R01 HD077592
6 · The paper itself

Abstract

objectiveThis study aimed to evaluate whether transient fetal growth restriction (FGR) that resolves prior to delivery confers a similar risk of neonatal morbidity as uncomplicated FGR that persists at term. STUDY

designThis is a secondary analysis of a medical record abstraction study of singleton live-born pregnancies delivered at a tertiary care center between 2002 and 2013. Patients with fetuses that had either persistent or transient FGR and delivered at 38 weeks or later were included. Patients with abnormal umbilical artery Doppler studies were excluded. Persistent FGR was defined as estimated fetal weight (EFW) <10th percentile by gestational age from diagnosis through delivery. Transient FGR was defined as EFW <10th percentile on at least one ultrasound, but not on the last ultrasound prior to delivery. The primary outcome was a composite of neonatal morbidity: neonatal intensive care unit admission, Apgar's score <7 at 5 minutes, neonatal resuscitation, arterial cord pH <7.1, respiratory distress syndrome, transient tachypnea of the newborn, hypoglycemia, sepsis, or death. Baseline characteristics and obstetric and neonatal outcomes were compared using Wilcoxon's rank-sum and Fisher's exact test. Log binomial regression was used to adjust for confounders.

resultsOf 777 patients studied, 686 (88%) had persistent FGR and 91 (12%) had transient FGR. Patients with transient FGR were more likely to have a higher body mass index, gestational diabetes, diagnosed with FGR earlier in pregnancy, have spontaneous labor, and deliver at later gestational ages. There was no difference in the composite neonatal outcome (relative risk = 1.03, 95% confidence interval [CI] 0.72, 1.47) for transient versus persistent FGR after adjusting for confounders (adjusted relative risk = 0.79, 95% CI 0.54, 1.17). There were no differences in cesarean delivery or delivery complications between groups.

conclusionNeonates born at term after transient FGR do not appear to have differences in composite morbidity compared with those where uncomplicated FGR persists at term. KEY POINTS: · No differences in neonatal outcomes in uncomplicated persistent versus transient FGR at term.. · Transient FGR pregnancies more likely to deliver at later gestational ages.. · No differences in mode of delivery or obstetric complications in persistent versus transient FGR at term..

Indexed as

Fetal Growth RetardationGestational AgeAdultApgar ScoreFemaleFetal WeightHumansHypoglycemiaInfant, NewbornIntensive Care Units, NeonatalMalePregnancyPregnancy OutcomeRespiratory Distress Syndrome, NewbornRetrospective StudiesSepsis

Identifiers

PMID36894159
PMCPMC10562520
OpenAlexW4323657599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.